Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Paediatric and Perinatal Epidemiology|August 19, 2014
The safe passage study: design, methods, recruitment, and follow-up approachKimberly A Dukes, Larry Burd, Amy J Elliott, et al.
Epilepsia|March 31, 2018
SCN1A variants associated with sudden infant death syndromeCatherine A Brownstein, Richard D Goldstein, Christopher H Thompson, et al.
Molecular & Cellular Proteomics : MCP|October 7, 2011
Brainstem deficiency of the 14-3-3 regulator of serotonin synthesis: a proteomics analysis in the sudden infant death syndromeKevin G Broadbelt, Keith D Rivera, David S Paterson, et al.
Alcohol (Fayetteville, N.Y.)|July 31, 2017
Drinking and smoking patterns during pregnancy: Development of group-based trajectories in the Safe Passage StudyKimberly Dukes, Tara Tripp, Marian Willinger, et al.
Leukemia|November 26, 2024
Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
High serum serotonin in sudden infant death syndromeRobin L Haynes, Andrew L Frelinger, Emma K Giles, et al.
Journal of Neuropathology and Experimental Neurology|February 7, 2024
Altered 5-HT2A/C receptor binding in the medulla oblongata in the sudden infant death syndrome (SIDS): Part II. Age-associated alterations in serotonin receptor binding profiles within medullary nuclei supporting cardiorespiratory homeostasisKevin J Cummings, James C Leiter, Felicia L Trachtenberg, et al.
Research Square|April 8, 2024
Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2025
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancerNicole C Schmitt, William A Stokes, James E Bates, et al.
Oncoimmunology|June 18, 2024
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescentBrendan L C Kinney, Brianna Brammer, Vikash Kansal, et al.
Pageof 30